Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: Novartis Pharmaceuticals, Simulect 10mg & 20mg powder and solvent for Solution for injection or infusion, EL (23)A/17

2023-05-16 12:58:47 (12 month(s) ago)

Summary

Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may contain glass fragments approximately 20 – 800 µm i…

Read full MHRA article

Respond to this alert